Reaction
Alveolar Proteinosis reporting signals
As of the last recalculation, Alveolar Proteinosis appears in 578 FAERS reports alongside 25 co-occurring drug terms. The strongest observed disproportionality signal is SIROLIMUS (PRR 90.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Sirolimus | 32 | 90.5 | 90.7 |
| Tacrolimus Ointment 0.1% | 161 | 64.1 | 64.2 |
| Tacrolimus Extended-Release Capsules | 161 | 64.0 | 64.1 |
| Anakinra | 27 | 61.4 | 61.5 |
| Tacrolimus | 174 | 56.8 | 56.9 |
| Prednisolone | 183 | 53.0 | 53.0 |
| Prednisolone Oral | 183 | 53.0 | 53.0 |
| Prednisolone Oral Solution | 183 | 53.0 | 53.0 |
| Canakinumab | 14 | 47.7 | 47.8 |
| Quinine | 10 | 42.7 | 42.8 |
| Everolimus Tablets | 19 | 42.2 | 42.2 |
| Baricitinib | 9 | 34.1 | 34.2 |
| Mycophenilic Acid | 18 | 32.3 | 32.3 |
| Mycophenolate Mofetil Hydrochloride | 100 | 31.8 | 31.8 |
| Mycophenolate Mofetil | 99 | 31.5 | 31.5 |
| Tofacitinib Citrate | 11 | 30.8 | 30.8 |
| Mycophenolic Acid | 25 | 29.4 | 29.4 |
| Bisacodyl Suppositories | 10 | 28.3 | 28.3 |
| Imatinib | 13 | 27.1 | 27.2 |
| Ganciclovir | 7 | 24.9 | 24.9 |
| Ganciclovir Sodium | 7 | 24.1 | 24.1 |
| Ruxolitinib | 39 | 20.9 | 21.0 |
| Busulfan | 9 | 20.9 | 20.9 |
| Vemurafenib | 4 | 12.1 | 12.1 |
| Carfilzomib | 9 | 11.6 | 11.6 |